Kelly E. Daniels

University of Pittsburgh, Thomas Jefferson University

Papers

Total Citations

H-Index

About

Dr. Kelly E. Daniels is a rising leader in otolaryngology–head and neck surgery, with a focused research program at the intersection of surgical oncology, patient safety, and evidence-based pain management. Her work has been instrumental in refining postoperative care for patients undergoing transoral robotic surgery (TORS) for oropharyngeal squamous cell carcinoma. In her most-cited study (2024, 8 citations), Dr. Daniels demonstrated that post-TORS hemorrhage can significantly delay adjuvant therapy, directly impacting survival outcomes—a critical finding that has reshaped perioperative monitoring protocols. She is equally recognized for her multiphasic work on opioid stewardship. Her landmark 2022 paper (6 citations) established that over 50% of postoperative opioids prescribed for common otolaryngologic procedures went unused. By translating these data into multimodal, evidence-based prescribing guidelines, Dr. Daniels has helped reduce unnecessary opioid exposure while maintaining effective pain control. Her contributions are not only clinically actionable but also align with national efforts to combat the opioid crisis. With a growing citation profile and a reputation for translating surgical outcomes into practice-changing guidelines, Dr. Daniels is shaping the future of safer, more effective head and neck cancer care.